newsfilter
← Latest News
ACCESS Newswire·

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

TÜBINGEN, DE / ACCESS Newswire / April 8, 2025 / CureVac N.V. , a global biotech company developing a new class of transformative medicines based on messenger ribonucleic acid